Medcorp Limited (TTSE:MED)

Medcorp Balance Sheet

Financials in millions TTD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	16.26	15.3	18.64	37.62	28.05	32.1
Short-Term Investments	15.4	15	-	-	-	-
Trading Asset Securities	-	-	-	-	-	0.68
Cash & Short-Term Investments	31.66	30.3	18.64	37.62	28.05	32.79
Cash Growth	51.90%	62.56%	-50.46%	34.15%	-14.46%	-9.02%
Accounts Receivable	20.7	25.72	25.73	28.85	12.31	21.47
Other Receivables	3.37	7.18	13.66	7.21	7.99	2.51
Receivables	24.07	32.9	39.4	36.06	20.29	23.98
Inventory	7.66	8.83	7.6	6.76	7.21	7.09
Prepaid Expenses	-	0.41	0.32	0.26	-	-
Total Current Assets	63.4	72.44	65.95	80.7	55.55	63.85
Property, Plant & Equipment	140.53	141.93	156.38	168.39	73.32	63.38
Long-Term Investments	12	11.42	10.41	7.55	8.96	12.64
Long-Term Deferred Tax Assets	-	-	-	-	-	0.26
Total Assets	215.92	225.79	232.74	256.65	137.83	140.15

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	19.38	10.47	22.16	16.1	32.96	32.93
Accrued Expenses	-	6.98	8.55	7.58	12.8	7.78
Short-Term Debt	-	3.32	7.29	6.84	5.74	8.31
Current Portion of Long-Term Debt	-	-	2.71	5.7	5.57	4.57
Current Portion of Leases	5.81	8.87	8.48	8.53	6.3	5.96
Current Income Taxes Payable	-	1.52	1.88	6.61	3.4	6.08
Other Current Liabilities	-	3.44	4.09	4.12	4.88	2.22
Total Current Liabilities	25.19	34.6	55.16	55.5	71.65	67.86
Long-Term Debt	-	-	0.15	2.85	8.57	5.03
Long-Term Leases	88.78	88.86	98.05	107.25	17.48	23.79
Long-Term Deferred Tax Liabilities	-	3.44	5.52	4.66	3.32	1.89
Other Long-Term Liabilities	-	-	-	-	-	-0
Total Liabilities	113.97	126.89	158.88	170.25	101.02	98.57

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	22.18	22.18	7.48	33.41	33.41	33.41
Retained Earnings	79.78	76.73	66.38	52.99	3.4	8.17
Shareholders' Equity	101.95	98.9	73.86	86.4	36.81	41.58
Total Liabilities & Equity	215.92	225.79	232.74	256.65	137.83	140.15

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	94.58	101.05	116.67	131.17	43.66	47.66
Net Cash (Debt)	-62.92	-70.75	-98.03	-93.54	-15.62	-14.88
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-8.17	-9.24	-13.11	-12.51	-2.09	-1.99
Filing Date Shares Outstanding	7.66	7.83	7.48	7.48	7.48	7.48
Total Common Shares Outstanding	7.66	7.83	7.48	7.48	7.48	7.48
Working Capital	38.2	37.84	10.78	25.21	-16.1	-4
Book Value Per Share	13.30	12.63	9.87	11.55	4.92	5.56
Tangible Book Value	101.95	98.9	73.86	86.4	36.81	41.58
Tangible Book Value Per Share	13.30	12.63	9.87	11.55	4.92	5.56
Machinery	-	123.96	122.27	118.47	110.26	88.97
Construction In Progress	-	-	-	-	2.71	8.49
Leasehold Improvements	-	8.04	7.97	7.32	7.23	5.28

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 14, 2026

Data Sources Report a data error